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IN 1959, Pietra, Spencer and Shubik demonstrated that small doses of 7,12-
dimethylbenz(a)anthracene (DMBA), injected once into newborn mice, induced a
high incidence of lymphoma. This work was soon confirmed and extended
(Pietra, Rappaport and Shubik, 1961; Roe, Rowson and Salaman, 1961; Kelly
and O'Gara, 1961) and it became apparent that the incidence oftumours at other
distant sites, notably the lungs, was also increased by such treatment. One
anomalous feature of these studies was that animals rarely developed sarcomata
at the site of injection of DMBA even though the substance was given in doses
sufficient to exert a carcinogenic effect at more distant sites; in adult mice, on the
other hand, the carcinogenic effects of DMBA tend to be almost confined to the
original site of its injection. This difference in response is reduced if the dose of
DMBA given at birth is very large; such animals subsequently develop a higher
proportion of local tumours and fewer distant neoplasms but the importance of
age is emphasised by experiments in which mice, injected once with DMBA at
various times after birth, showed a gradual change from the " neonatal " to the
"adult " type of carcinogenic response (Toth, Rappaport and Shubik, 1963).
Other factors beside age are also involved. It is now well-established that the
pattern of " distant " carcinogenesis in newborn mice varies amongst different
strains (Kelly and O'Gara, 1961; Roe, Rowson and Salaman, 1961; Trainin,
Precerutti and Law, 1964; Roe and Walters, 1967) and it is also apparent that
new-born animals of other species may respond in a different fashion. Species
other than the mouse have been studied less intensively but it is clear that
in baby rats (Toth and Shubik, 1963) and also in baby hamsters (Lee, Toth and
Shubik, 1963; Walters, Roe and Levene, 1967) a single injection of DMBA
induces local, rather than distant, tumours-these animals show a high incidence
of injection site neoplasms but there is no striking increase in lymphomas or in
pulmonary adenomas. This variation in response to carcinogens amongst
different species prompted the present investigation in which the effects ofDMBA
have been studied in new-born rabbits.
MATERIALS AND METHODS
Rabbits.-Forty-three newborn New Zealand Red Rabbits were obtained from
7 litters; their birth weights ranged from 43 to 75 g. They were weaned at
approximately 4 weeks and kept in metal cages, either singly or in pairs. They
were maintained on diet S.G.1. (Messrs. Dixon Ltd., Ware, Herts.) and water
ad libitum supplemented, on alternate days, by cabbage and hay.816 F. J. C. ROE, R. L. CARTER AND W. H. PERCIVAL
Chemicals.-7,12-Dimethylbenz(a)anthracene (DMBA) was obtained from
L. Light & Co.; gelatin from British Drug Houses.
Preparation and administration of DMBA. A suspension of DMBA in 3 %°
aqueous gelatin was prepared by adding an acetone solution of the compound to
aqueous gelatin, warmed to 560 C. The acetone was driven off in a stream of
nitrogen while the temperature was maintained at 560 C. The final concentration
of DMBA in aqueous gelatin was 25 mg./10 ml. Rabbits in the test group
received a single dose of DMBA 0-1 ml. (250 #tg.)/10 g. body weight; (actual
doses ofDMBA thus ranged from 1.0 to 1-75 mg.). Animals in the control group
received a single dose of 3 % aqueous gelatin 0X1 ml./10 g. body weight. All
injections were given subcutaneously in the interscapular region within 24 hours
ofbirth. Details ofthe treatment received by members ofeach ofthe 7 litters are
shown in Table I.
TABLE J.--Experimental Details
Test Group Control Group
DMBA 0-1 ml. (250 yg.) 3% aqueous gelatin
Number of 10 g. body weight 0.1 ml./10 g.
Litter rabbits in 3% aqueous gelatin body weight
1 7 7 0
2 6 5 . 1
3 . 7 4 . 3
4 . 7 5 . 2
5 . 6 4 . 2
6 6 4 . 2
7 . 4 0 . 4
Totals: 43 29 . 14
Subsequent conduct of the experiment.-The animals were observed daily and
examined for tumours and other lesions at weekly intervals. Sick rabbits were
killed with nembutal. The experiment was terminated by the killing ofsurvivors
156 weeks after the start ofthe experiment. Complete post-mortem examinations
were carried out and tumours and any tissues which showed macroscopic abnorm-
alities were removed and fixed in Bouin's solution. 5,# Paraffin sections were
prepared and stained with haematoxylin and eosin and, where necessary, with
Foot's silver impregnation technique for reticulin fibres and with haematoxylin
and Van Gieson.
RESULTS
Mainly as a result of rejection of injected animals by their mothers, only
25 rabbits (17 treated with DMBA and 8 control animals) survived the first few
days of life. Since control as well as treated animals died there is no reason to
attribute these deaths to DMBA toxicity. Despite the high mortality, the
findings in the survivors were clear-cut; they are summarised in Table II.
Tumours at the site of injection were seen in 7 out of 17 rabbits treated at birth
with a single dose of DMBA. The period of induction of these lesions was some-
what protracted and in only 2 animals were tumours palpable at 52 weeks. Once
apparent, all the tumours grew progressively although their rate of growth was
variable, the interval between the appearance of a palpable lesion and the time of
autopsy ranging from 15 to 32 weeks. Six of the 7 rabbits which developed
subcutaneous sarcomata were males but since males predominated amongst the-CARCINOGENESIS AND DMBA
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surviving test animals (11, as opposed to 6 females) this sex difference is difficult to
evaluate. The tumours were single except in one rabbit where three separate
sarcomata developed at the injection site.
Three ofthe injection site tumours were classified histologically as pleomorphic
sarcomata, and 4 were regarded as spindle cell lesions (Fig. 1 and 2). The pleo-
morphic tumours contained variable numbers of multinucleate cells and mitotic
figures were common in some zones. The spindle cell sarcomata showed greater
differentiationand a variableamountofcollagenformation. Bothtypes oftumour
contained regions of haemorrhage and necrosis and myxomatous degeneration was
prominent in some of ihe spindle cell lesions. The histological features of the
tumours correlated closely with their biological activity. The fastest rates of
growth were seen in the pleomorphic sarcomata, 2 of which produced early
ulceration of the overlying epidermis. Again, metastases were found in all 4
rabbits which developed pleomorphic sarcomata but in only 1 animal with a
spindle cell sarcoma (Fig. 3-5): the sites involved, in decreasing order of fre-
quency, were lungs, liver, kidneys, spleen and heart.
Apart from the local tumours, the yield of other neoplasms in animals treated
at birth with DMBA was meagre. One pulmonary adenoma and a bile duct
carcinoma (Fig. 6) were seen. Both these tumours were encountered in animals
which did not develop injection site sarcomata and their relationship to treatment
with DMBA is uncertain. No lymphomas were observed.
The control rabbits, injected at birth with aqueous gelatin, did not develop
any local or distant neoplasms in the course of the experiment. Pneumonia,
chronic nephritis, and hepatic coccidiosis of various degrees of severity were seen
in both test and control rabbits, and there was no evidence that treatment with
DMBA influenced either the incidence or severity of these conditions.
DISCUSSION
Although the rabbit was frequently used in early investigations on chemical
carcinogenesis, later workers have tended to favour rats and mice (Hartwell, 1951;
Shubik and Hartwell, 1957). Despite numerous studies on the effects of carcino-
gens in newborn animals, rabbits do not appear to have been investigated previ-
ously. The present work establishes 2 main points. First, new-born rabbits are
EXPLANATION OF PLATES
NOTE all photomicrographs are stained with haematoxylin and eosin and are
shown at a magnification of x 110.
FIG. 1 and 2. Subcutaneous sarcomata developing at the site of injection of DMBA,
administered within 24 hours of birth.
FIG. 1. Spindle cell sarcoma. DMBA injected 71 weeks previously
FIG. 2. Pleomorphic sarcoma. DMBA injected 60 weeks previously.
FIG. 3 to 5. Metastases from subcutaneous sarcomata.
FIG. 3. Two metastatic deposits of sarcoma in the lungs.
FIG. 4. Deposit of sarcoma in the myocardium.
FIG. 5. Secondary sarcoma in the renal parenchyma.
FIG. 6. Bile duct carcinoma; this rabbit was treated at birth with DMBA but did not develop
a tumour at the site of injection.
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clearly sensitive to the carcinogenic action of a single subcutaneous injection of
DMBA. Inthisregard, therefore, theyresemble the other specieswhich have been
examined in the past. Secondly, the effects of DMBA appear to be mainly
localised to the site ofinjection; subcutaneous sarcomata are readily induced but
the distant target organs which are so frequently affected in mice-especially
the lung and lymphoid tissues-respond, if at all, only to a very limited extent.
(Because of the small size of the control group, it is not possible to be certain
whether the pulmonary adenoma or bile duct carcinoma seen in DMBA treated
rabbits should be attributed to treatment).
The high mortality rate during the first few days of life was caused by canni-
balism or maternal neglect rather than by acute toxicity of DMBA, since rabbits
from both test and control groups were equally affected. The main complication
which this increased neonatal mortality has introduced into the present investi-
gation is that the significance of the apparent excess of male rabbits which
developed subcutaneous sarcomatais obscured. In several otherreports, however,
neonatal injection of carcinogens into other species has produced a higher inci-
dence of tumours in males than in females (Chieco-Bianchi, de Benedictis,
Tridente and Fiore-Donati, 1963; Nishizuka, Ito and Nakakuki, 1965; Roe and
Walters, 1967).
Most ofthe subcutaneous sarcomata which were induced by DMBA developed
during the second year of the experiment. Their histology was unremarkable
although a rather close relationship was found between the presence ofan undiffer-
entiated pleomorphic tumour and the development of metastases. Secondary
deposits were seen in 5 outofthe 7 animalswithinjection site sarcomata, sometimes
at unusual sites such as the heart and spleen. The subcutaneous sarcomata
induced by DMBA in newborn hamsters also tended to disseminate (Lee, Toth and
Shubik, 1963); in baby rats, on the other hand, metastasis from injection site
tumours occurred in only one instance (Toth and Shubik, 1963).
The absence oflymphomas and the occurrence of a single pulmonary adenoma
has already been stressed. The only other distant tumour which developed was
a bile duct carcinoma. The relationship of this lesion to treatment with DMBA
is obscure. But it is doubtful whether such tumours develop spontaneously in
rabbits and, furthermore, it is interesting that other examples ofbile duct tumours
have also been reported after treatment with DMBA at birth in C57B1 mice
(Baroni and Cefis, 1963) and in hamsters (Lee, Toth and Shubik, 1963).
On present evidence, it appears that newborn animals respond to a single dose
ofDMBA in 1 of 2 ways. In baby mice, DMBA acts primarily on distant tissues
andthe yieldoflocalneoplasms islow. Innew-bornrats andhamsters, thereverse
situation is seen andthere is apreponderance oftumours at the injection site. The
present investigation shows that new-born rabbits resemble rats and hamsters
in their response to DMBA rather than mice. However, more information on the
effects of different doses and also of different solvents (cf. Walters, Roe, Mitchley
and Walsh, 1967) is needed before this general conclusion can be fully accepted.
SUMMARY
Twenty-nine newbornNewZealand Red Rabbitsreceived asingle subcutaneous
injection of 7,12-dimethylbenz(a)anthracene (DMBA) in 3 % aqueous gelatin
(0.1 ml./ 10 g. body weight of a suspension containing 250 ,ug. DMBA/ml.); 14
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animals received 3 0. aqueous gelatin only. Pleomorphic and spindle cell sar-
comata developed at the injection site in 7 out of 17 rabbits which were treated
with DMBA. The mean period of induction of these tumours was 67-4 weeks.
Metastases were present in 5 animals. The incidence of other distant tumours
was strikingly low; 1 pulmonary adenoma and 1 bile duct carcinoma were
encountered but no lymphomas were found. No neoplasms developed in rabbits
from the control groups, injected with 3 % aqueous gelatin.
The results are discussed and it is stressed that the effects of DMBA, injected
subcutaneously into newborn rabbits, are similar to those previously described
in neonatal rats and hamsters. In all these species, DMBA acts principally at
the site of application and distant tumours are uncommon. These findings are
contrasted with the effects ofDMBA in newborn mice in which there is a predomi-
nance of distant neoplasms and few local tumours. Further studies on the
influence of dose and solvent in different species are needed.
We are indebted to Mr. K. G. Moreman for the photomicrographs. This
investigation was supported by grants to the Chester Beatty Research Institute
(Institute ofCancer Research: Royal Cancer Hospital), from the Medical Research
Council, the British Empire Cancer Campaign for Research, and the National
Cancer Institute, United States Public Health Service.
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